Virology Market Growing Demands, 2022 | Latest Innovations, Industry Size-Share, Key Development Trends, Market Performance, Product Situation, Growth Opportunities, Competitive Situation, and Future Market Outlook Till 2028
01 sept. 2022 08h38 HE
|
Industry Research
Pune, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Global “Virology Market” 2022-2028 report discovers comprehensive insights on key manufacturers with share information, market size and projection, key...
Insights on the Bioanalytical Testing Services Global Market to 2027 - Emerging Countries in the Asia Pacific Region Present Opportunities
12 août 2022 04h28 HE
|
Research and Markets
Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Bioanalytical Testing Services Market (2022-2027) by Type, Application, End-User, Geography, Competitive Analysis and the Impact of Covid-19...
Provectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
23 juin 2022 09h41 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, June 23, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s shareholders have approved the proposals of Provectus’ Board of Directors (Board) to seek...
Global OTC/DTC Infectious Disease Diagnostics Market Report 2022-2026: Sleeping Giant of Over the Counter and Direct to Consumer Diagnostics is Set to Create a Broad New Diagnostic Industry
17 juin 2022 04h13 HE
|
Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct To Consumer. Forecasts by Application by Channel by...
Provectus Biopharmaceuticals Seeks Stockholder Approval at 2022 Annual Meeting for Authority to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
19 avr. 2022 16h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 19, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that, in conjunction with the filing of the Company’s preliminary 2022 proxy statement (Pre-14A), Provectus’...
Global Molecular Diagnostics at the Point of Care Markets, 2022-2027: COVID-19 Pandemic Drives Point of Care Diagnostics into Hypergrowth
18 avr. 2022 04h53 HE
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics at the Point of Care: By Application, Technology, Place, Product and by Country, with COVID-19 PoC Breakout and Executive...
Provectus Biopharmaceuticals Names Aru Narendran, MD, PhD to Scientific Advisory Board
14 avr. 2022 07h30 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 14, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced the addition of Aru Narendran, MD, PhD to the Company’s Scientific Advisory Board. Dr. Narendran is a...
World OTC/DTC Infectious Disease Diagnostics Markets, Strategies and Trends Report 2022
14 avr. 2022 04h13 HE
|
Research and Markets
Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market...
Global Molecular Diagnostics for Infectious Disease Market Research Report 2022: New Genotypes Creating New Markets / Developing World Driving ID Dx Growth
24 mars 2022 06h18 HE
|
Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With COVID-19 Impact & Forecasting/Analysis, and Executive...
Dr. William Haseltine releases new book on Innate Immunity and Covid-19
16 mars 2022 13h37 HE
|
ACCESS Health International
New York, March 16, 2022 (GLOBE NEWSWIRE) -- In his latest book, bestselling author William A. Haseltine Ph.D. tells us that understanding our natural immunity to the SARS-CoV-2 virus is critical...